The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns in prostate cancer patients who received darolutamide in the ARAMIS trial in Spain: PARASEC study.
 
Javier Puente
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma; Merck (Inst); Pfizer; Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Janssen-Cilag; Merck Serono; MSD Oncology; Pfizer; Roche
 
José García Sánchez
Consulting or Advisory Role - Boehringer Ingelheim; Eisai Europe; EUSA Pharma; PharmaMar; Roche; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
 
Joan Folqué
Employment - BAYER HISPANIA SL; Ipsen (I)
 
Javier Casas
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Janssen
Research Funding - Astellas Pharma; Bayer; Janssen
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Janssen